Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection (2024)
- Authors:
- Autor USP: KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1126/scitranslmed.ade5795
- Subjects: VETORES; FEBRE AMARELA; BRASIL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2024
- Source:
- Título do periódico: Science translational medicine
- ISSN: 1946-6234
- Volume/Número/Paginação/Ano: v. 15, n. 689, article ID eade5795, 10p, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
RICCIARDI, Michael J et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, v. 15, n. 689, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53922. Acesso em: 27 abr. 2024. -
APA
Ricciardi, M. J., Rust, L. N., Pedreno-lopez, N., Yusova, S., Biswas, S., Webb, G. M., et al. (2024). Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, 15( 689). doi:10.1126/scitranslmed.ade5795 -
NLM
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922 -
Vancouver
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 abr. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922 - Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
- Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil
- A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results
- Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection
- Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
- Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
- Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus
- A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents
- Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation
- Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil
Informações sobre o DOI: 10.1126/scitranslmed.ade5795 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
